Innovent Biologics, Inc. (FRA:6IB)
Germany · Delayed Price · Currency is EUR 9.70
0.00 (0.00%)
At close: Jan 9, 2026
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of €16.95 billion as of January 12, 2026. Its market cap has increased by 133.14% in one year.
Market Cap
16.95B
Enterprise Value
16.20B
Revenue
1.36B
Ranking
n/a
PE Ratio
125.92
Stock Price
€9.70
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.09B to 16.95B, an increase of 711.41%. That is a compound annual growth rate of 33.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 16.95B | 18.04% |
| Dec 31, 2025 | 14.36B | 92.58% |
| Dec 31, 2024 | 7.46B | -6.93% |
| Dec 29, 2023 | 8.01B | 29.87% |
| Dec 30, 2022 | 6.17B | -22.46% |
| Dec 31, 2021 | 7.96B | -34.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |